Submitted by Anonymous (not verified) on 15 June 2026 - 12:00
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised